- Report
- March 2023
- 190 Pages
Germany
From €2195EUR$2,490USD£1,928GBP
- Report
- March 2023
- 130 Pages
Japan
From €2195EUR$2,490USD£1,928GBP
- Report
- March 2023
- 190 Pages
Switzerland
From €2195EUR$2,490USD£1,928GBP
- Report
- February 2023
- 130 Pages
France
From €2195EUR$2,490USD£1,928GBP
- Report
- February 2023
- 130 Pages
Canada
From €2195EUR$2,490USD£1,928GBP
- Report
- February 2023
- 120 Pages
Israel
From €2195EUR$2,490USD£1,928GBP
- Report
- September 2020
- 168 Pages
Netherlands
From €1754EUR$1,990USD£1,541GBP
- Report
- January 2023
- 180 Pages
Netherlands
From €2195EUR$2,490USD£1,928GBP
- Report
- July 2025
- 200 Pages
Saudi Arabia
From €2195EUR$2,490USD£1,928GBP
- Report
- November 2024
- 70 Pages
Australia
From €2195EUR$2,490USD£1,928GBP
- Report
- July 2023
- 220 Pages
Global
From €1754EUR$1,990USD£1,541GBP
- Report
- February 2023
- 190 Pages
Sweden
From €2195EUR$2,490USD£1,928GBP
- Report
- January 2023
- 190 Pages
United Kingdom
From €2195EUR$2,490USD£1,928GBP
- Report
- January 2023
- 125 Pages
United States
From €2195EUR$2,490USD£1,928GBP
- Report
- April 2021
China
From €2292EUR$2,600USD£2,013GBP
- Report
- November 2018
- 30 Pages
China
From €1940EUR$2,200USD£1,704GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €2645EUR$3,000USD£2,323GBP
€3306EUR$3,750USD£2,904GBP
- Report
- July 2024
- 150 Pages
Global
From €2645EUR$3,000USD£2,323GBP
€3306EUR$3,750USD£2,904GBP
- Report
- November 2023
- 30 Pages
Global
From €1940EUR$2,200USD£1,704GBP
€2424EUR$2,750USD£2,129GBP
- Report
- November 2023
- 30 Pages
Global
From €1940EUR$2,200USD£1,704GBP
€2424EUR$2,750USD£2,129GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more